• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials - What do we Consolidate and how do we Plan for the Future?

作者信息

Iyngkaran Pupalan, Thomas Merlin, Majoni Sandawana W

机构信息

Consultant Cardiologist Heart West and Senior Lecturer Flinders University, NT Medical School, Darwin, Australia.

Biochemistry of Diabetes Complications, The Department of Diabetes, Monash University, Melbourne, Australia.

出版信息

Curr Cardiol Rev. 2019;15(3):158-160. doi: 10.2174/1573403X1503190506101720.

DOI:10.2174/1573403X1503190506101720
PMID:31084591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6719389/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdac/6719389/f71fcb3d864f/CCR-15-158-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdac/6719389/f71fcb3d864f/CCR-15-158-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdac/6719389/f71fcb3d864f/CCR-15-158-F1.jpg

相似文献

1
Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials - What do we Consolidate and how do we Plan for the Future?超越随机对照试验优化慢性心力衰竭护理的观点——我们该巩固什么以及如何规划未来？
Curr Cardiol Rev. 2019;15(3):158-160. doi: 10.2174/1573403X1503190506101720.
2
Patient care. Disease dilemma. Can a case be made for programs that improve health, but may not reduce costs?患者护理。疾病困境。对于那些改善健康状况但可能无法降低成本的项目，能找到支持的理由吗？
Hosp Health Netw. 2005 Apr;79(4):24, 26.
3
Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.在未来的随机试验中应对心力衰竭的异质性
Curr Heart Fail Rep. 2017 Jun;14(3):197-202. doi: 10.1007/s11897-017-0332-1.
4
Does Evidence Drive Fluid Volume Restriction in Chronic Heart Failure?证据是否推动慢性心力衰竭患者的液体量限制？
Nurs Clin North Am. 2017 Jun;52(2):261-267. doi: 10.1016/j.cnur.2017.01.003.
5
The effects and cost-effectiveness of an empowerment-based self-care programme in patients with chronic heart failure: A study protocol.基于赋能的自我护理方案对慢性心力衰竭患者的效果及成本效益研究：研究方案
J Adv Nurs. 2019 Dec;75(12):3740-3748. doi: 10.1111/jan.14162. Epub 2019 Aug 27.
6
Cardiac resynchronization therapy in patients with New York Heart Association class I and II heart failure: an approach to 2010.纽约心脏协会心功能I级和II级心力衰竭患者的心脏再同步治疗：2010年的治疗方法
Circulation. 2010 Sep 7;122(10):1037-43. doi: 10.1161/CIRCULATIONAHA.109.923094.
7
Non-specific immunomodulation in chronic heart failure.慢性心力衰竭中的非特异性免疫调节
Lancet. 2008 Jun 21;371(9630):2083; author reply 2084. doi: 10.1016/S0140-6736(08)60913-7.
8
[Future perspectives in the treatment of heart failure: from cell transplantation to cardiac regeneration].[心力衰竭治疗的未来展望：从细胞移植到心脏再生]
Rev Esp Cardiol. 2004 Oct;57(10):981-8.
9
Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.慢性心力衰竭的生物标志物引导治疗：随机对照试验的荟萃分析
Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9.
10
Cardiac resynchronization therapy in chronic heart failure.慢性心力衰竭的心脏再同步治疗
Br J Hosp Med (Lond). 2008 Jul;69(7):392-8. doi: 10.12968/hmed.2008.69.7.30415.

本文引用的文献

1
Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age.从心力衰竭指南到临床实践：导致多重合并症和老年患者再入院的差距
Clin Med Insights Cardiol. 2018 Dec 4;12:1179546818809358. doi: 10.1177/1179546818809358. eCollection 2018.
2
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018.澳大利亚国家心脏基金会以及澳大利亚和新西兰心脏学会：《2018年澳大利亚心力衰竭预防、检测与管理指南》
Heart Lung Circ. 2018 Oct;27(10):1123-1208. doi: 10.1016/j.hlc.2018.06.1042.
3
: Type 2 Diabetes and Readmission for Heart Failure.
2型糖尿病与心力衰竭再入院
Clin Med Insights Cardiol. 2018 Jun 5;12:1179546818779588. doi: 10.1177/1179546818779588. eCollection 2018.
4
Editorial: Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials - What are the problem areas and potential solutions?社论：超越随机对照试验优化慢性心力衰竭护理——问题领域和潜在解决方案有哪些？
Curr Cardiol Rev. 2016;12(3):164-5. doi: 10.2174/1573403x1203160715234005.
5
Heart Failure Pharmacotherapy and Supports in the Elderly - A Short Review.老年人心力衰竭的药物治疗与支持——简短综述
Curr Cardiol Rev. 2016;12(3):180-5. doi: 10.2174/1573403x12666160622102802.
6
Phase 4 Studies in Heart Failure - What is Done and What is Needed?心力衰竭的4期研究——已做之事与所需之事？
Curr Cardiol Rev. 2016;12(3):216-30. doi: 10.2174/1573403x12666160606121458.
7
Type 2 Diabetes and Heart Failure: Challenges and Solutions.2型糖尿病与心力衰竭：挑战与解决方案
Curr Cardiol Rev. 2016;12(3):249-55. doi: 10.2174/1573403x12666160606120254.
8
Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria.慢性心力衰竭的床边到实验室转化研究：为不符合试验入组标准的患者制定议程。
Clin Med Insights Cardiol. 2015 Aug 5;9(Suppl 1):121-32. doi: 10.4137/CMC.S18737. eCollection 2015.
9
Northern Territory perspectives on heart failure with comorbidities – understanding trial validity and exploring collaborative opportunities to broaden the evidence base.北领地对合并症心力衰竭的看法——理解试验有效性并探索合作机会以拓宽证据基础。
Heart Lung Circ. 2015 Jun;24(6):536-43. doi: 10.1016/j.hlc.2014.12.007. Epub 2014 Dec 24.
10
Technology-assisted congestive heart failure care.技术辅助的充血性心力衰竭护理。
Curr Heart Fail Rep. 2015 Apr;12(2):173-86. doi: 10.1007/s11897-014-0251-3.